5G3 TalkMed
- 0.420
- +0.005+1.20%
TalkMed News
TalkMed Reaches Final Settlement in Mediation Related to Claims in Stem Med Stake Disposal
TalkMed (SGX:5G3) has agreed to a full and final settlement after attending mediation in a legal proceeding related to the disposal of its entire stake in Stem Med to Edge Capital Fund SP2 (ECF), acco
TalkMed Group Settles High Court Litigation
Here's Why We Think TalkMed Group (SGX:5G3) Might Deserve Your Attention Today
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage
TalkMed Group Signals Potential Acquisition Talks
Is TalkMed Group Limited's (SGX:5G3) Stock Price Struggling As A Result Of Its Mixed Financials?
TalkMed Group Awards 1.1 Million New Shares
TalkMed Group (SGX:5G3) allotted and issued 1.1 million ordinary shares, pursuant to its performance share plan, according to a company filing on the Singapore Exchange on Wednesday. Following the iss
TalkMed's H2 Attributable Profit Falls on Wider Impairment Loss
TalkMed Group (SGX:5G3) registered a lower profit attributable to owners for the second half of 2023 despite higher revenue after impairment losses widened. The cancer care services provider's attribu
TalkMed Group Grants Nearly 8 Million Share Awards Under Performance Share Plan
Healthcare services provider TalkMed Group (SGX:5G3) granted 7,692,000 share awards to eligible employees of the group under its performance share plan on Tuesday. The awards will vest progressively w
TalkMed Group (SGX:5G3) Investors Are Sitting on a Loss of 20% If They Invested Five Years Ago
TalkMed Group Issues New Shares Upon Vesting of Share Awards
TalkMed Group (SGX:5G3) allotted and issued 499,999 new ordinary shares on Monday upon vesting of share awards that were granted on Oct. 15, 2021 under the company's performance share plan. Following
With EPS Growth And More, TalkMed Group (SGX:5G3) Makes An Interesting Case
Singapore Stocks Track Global Gains to Close Higher; Delfi Shares Jump 3% on Higher H1 Profit, Revenue
Singapore's Straits Times Index opened some eight points higher on Tuesday and closed marginally in green at the end of the session, tracking overnight gains in the US and Europe. During the day, the
TalkMed Group's Attributable Profit Zooms 18% in H1
TalkMed Group (SGX:5G3) logged a profit attributable to the owners of SG$14.3 million in the first half of the year, up 17.7% from SG$12.1 million a year ago. Earnings per share jumped to SG$0.0107 du
TalkMed Group Establishes New Subsidiary for Cell, Gene Therapy
TalkMed Group (SGX:5G3) has teamed up with StemCord to establish a majority-owned subsidiary named BioCell Innovations. BioCell Innovations will be involved in the development of novel processing plat
Are TalkMed Group Limited's (SGX:5G3) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
TalkMed Group Issues Nearly 2 Million Shares Upon Vesting of Share Awards
06:14 AM EDT, 03/14/2023 (MT Newswires) -- TalkMed Group (SGX:5G3) allotted and issued 1,945,210 new ordinary shares on Monday upon vesting of share awards that were granted on March 13, 2020 under th
Why TalkMed Group's (SGX:5G3) Earnings Are Better Than They Seem
TalkMed Group Limited's (SGX:5G3) recent earnings report didn't offer any surprises, with the shares unchanged over the last week. We did some digging, and we think that investors are missing some en
TalkMed Logs Higher Profit, Revenue in H2
06:49 AM EST, 02/23/2023 (MT Newswires) -- TalkMed Group (SGX:5G3) logged a higher profit attributable to the owners of SG$18.4 million in the second half of 2022, compared with SG$14.3 million a year
With 76% Ownership, TalkMed Group Limited (SGX:5G3) Insiders Have a Lot Riding on the Company's Future
TalkMed Group Limited's (SGX:5G3) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Analysis
Price Target
No Data
